Connect with us

Technology

Digital Pathology Market size is set to grow by USD 1.12 billion from 2024-2028, Growing adoption of IoT infrastructure among laboratories boost the market, Technavio

Published

2 years ago

on

NEW YORK, July 31, 2024 /PRNewswire/ — The global digital pathology market size is estimated to grow by USD 1.12 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of almost 16.98% during the forecast period. Growing adoption of iot infrastructure among laboratories is driving market growth, with a trend towards integration of ai into digital pathology systems. However, issues regarding privacy and safety of a digital database poses a challenge.Key market players include 3DHISTECH Ltd., Apollo Enterprise Imaging Corp., Co Diagnostics Inc., Corista, Danaher Corp., F. Hoffmann La Roche Ltd., General Electric Co., Hamamatsu Photonics KK, Huron Digital Pathology, Indica Labs Inc., Inspirata Inc., Kanteron Systems SLU, Koninklijke Philips N.V., Mikroscan Technologies Inc., Objective Pathology Services, Olympus Corp., Proscia Inc., Sectra AB, Visiopharm AS, and XIFIN Inc..

Get a detailed analysis on regions, market segments, customer landscape, and companies- View the snapshot of this report

Digital Pathology Market Scope

Report Coverage

Details

Base year

2023

Historic period

2018 – 2022

Forecast period

2024-2028

Growth momentum & CAGR

Accelerate at a CAGR of 16.98%

Market growth 2024-2028

USD 1124.2 million

Market structure

Fragmented

YoY growth 2022-2023 (%)

14.12

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 39%

Key countries

US, UK, Germany, France, and Canada

Key companies profiled

3DHISTECH Ltd., Apollo Enterprise Imaging Corp., Co Diagnostics Inc., Corista, Danaher Corp., F. Hoffmann La Roche Ltd., General Electric Co., Hamamatsu Photonics KK, Huron Digital Pathology, Indica Labs Inc., Inspirata Inc., Kanteron Systems SLU, Koninklijke Philips N.V., Mikroscan Technologies Inc., Objective Pathology Services, Olympus Corp., Proscia Inc., Sectra AB, Visiopharm AS, and XIFIN Inc.

Market Driver

The integration of artificial intelligence (AI) in digital pathology is revolutionizing clinical workflows, particularly in image analysis and machine-learning algorithms. Whole slide scanning technology, combined with AI, offers efficient image recognition and automated diagnostic capabilities. Market vendors are developing AI-powered software for digital pathology, focusing on automation in image analytics, decision-making, and result interpretations. These intelligent applications address the shortage of trained pathology professionals, fueling demand for AI-integrated digital pathology systems. Notable vendors, like Indica Labs and Visiopharm AS, have already launched AI-based platforms, HALO AI and Oncotopix, respectively. Meanwhile, other companies, including Huron Technologies International, Danaher, and Koninklijke Philips, are continuously enhancing their AI platforms and applications through strategic initiatives, which is anticipated to boost sales and increase the commercial availability of these systems during the forecast period.

The Digital Pathology market is experiencing significant growth due to the adoption of advanced technologies like Pathology Software, Pathology Imaging Systems, and Whole Slide Imaging. Pathology vendors are developing innovative solutions, including Pathology Training platforms and AI Integration for improved accuracy and efficiency. Pathology Data Security and Sharing are crucial concerns, with vendors focusing on robust systems for safeguarding patient information. Telepathology and Virtual Microscopy enable remote consultations and second opinions, enhancing patient care. Pathology Informatics and Analytics provide valuable insights, while Decision Support systems aid in faster and more accurate diagnoses. Digital Pathology Workstations and Workflow solutions streamline processes, and Collaboration tools facilitate seamless communication among healthcare professionals. Digital Pathology Services offer comprehensive solutions, including Reporting and Integration with Electronic Health Records. AI Pathology algorithms are revolutionizing diagnosis, offering precision and consistency. Overall, the Digital Pathology market is transforming Pathology Technology, offering numerous benefits to patients and healthcare providers alike.

Discover 360° analysis of this market. For complete information, schedule your consultation – Book Here!

Market Challenges

Digital pathology systems have streamlined laboratory processes by enabling digital acquisition, storage, manipulation, viewing, sharing, and transmission of glass slide images. However, the security and safety of these digital pathology data have become a significant concern for hospitals, reference laboratories, research institutes, and other end-users. The primary apprehensions revolve around the use of dependable data storage architectures. With the declining cost of cloud-based storage, digital pathology system providers advocate for cloud-based storage solutions due to their customized storage capabilities, capable of handling large data sizes, ranging from 1.2GB to 2GB per slide. However, cloud-based services are susceptible to external breaches, which could result in data loss and security breaches, potentially damaging the reputation and trust of end-user organizations. The increasing number of pathology data breaches worldwide has intensified the need for data safety services and heightened spending on securing sensitive databases. These concerns may hinder the growth of the digital pathology market during the forecast period.The Digital Pathology market is experiencing significant growth due to the adoption of advanced technologies like Whole Slide Imaging, Telepathology, and AI Pathology. Pathology software vendors are meeting the demand for digital solutions, providing tools for image storage, retrieval, and sharing. Pathology training and education are essential for effective implementation, with a focus on data security and patient care. Pathology imaging systems and scanners are key components, offering high-quality images for accurate diagnosis. Pathology workstations and decision support systems aid in efficient diagnosis and reporting. AI integration and analytics enhance diagnostic capabilities, enabling faster and more accurate results. Pathology informatics and digital pathology solutions streamline workflow and collaboration, enabling remote second opinions and integration with electronic health records. Data security remains a top concern, with solutions ensuring secure storage and sharing of sensitive patient information. The market trends include virtual microscopy, digital archiving, and telepathology services, offering convenience and cost savings. Overall, digital pathology technology is revolutionizing the field, improving patient care and diagnostic accuracy.

For more insights on driver and challenges – Request a sample report!

Segment Overview

This digital pathology market report extensively covers market segmentation by

Product1.1 Digital slide scanner1.2 SoftwareApplication2.1 Hospitals and laboratories2.2 Independent and small clinics2.3 Research centersGeography3.1 North America3.2 Europe3.3 Asia3.4 Rest of World (ROW)

1.1 Digital slide scanner- The digital slide scanner segment holds the largest share in the global digital pathology market due to the increasing adoption in academic institutions for research activities and the enhanced resolution of slide images. Technological advancements in slide magnification and scanning further fuel the segment’s growth. Notable developments, such as Hamamatsu Photonics’ launch of the NanoZoomer S20MD Slide scanner system, which scans a slide every 30 seconds, enable pathologists to focus more on analysis. Rising internet bandwidth connectivity and continuous technological improvements from market vendors contribute to the market’s expansion.

For more information on market segmentation with geographical analysis including forecast (2024-2028) and historic data (2017-2021) – Download a Sample Report

Research Analysis

Digital Pathology is a subspecialty of pathology that utilizes digital images of glass slides for diagnosis and analysis. Pathology Software is essential for managing and interpreting these images, enabling features such as Whole Slide Imaging, Telepathology, and AI Pathology. Virtual Microscopy and Remote Pathology allow pathologists to access and review slides from anywhere, while Pathology Informatics and Pathology Workflow solutions streamline the diagnostic process. Pathology Reporting and Integration ensure seamless communication between healthcare providers, and Pathology Cloud Storage provides secure, accessible storage for digital slides. Pathology Market Trends include increasing adoption of digital pathology, advancements in AI algorithms, and the integration of teleconsultation and quality assurance measures. Pathology Imaging Systems, Pathology Scanners, and Pathology Laboratories are key components of digital pathology workflows, while Pathology Management solutions help optimize operations and improve efficiency. Pathology AI Algorithms and Pathology Software Vendors continue to innovate and drive the digital pathology market forward.

Market Research Overview

Digital Pathology is a rapidly evolving field that leverages technology to enhance traditional pathology practices. It includes Pathology Software solutions, such as Whole Slide Imaging (WSI) and Virtual Microscopy, which enable the digitization and remote viewing of glass slides. Telepathology and AI Pathology are key components, offering real-time consultations and advanced diagnostic capabilities through AI algorithms. Pathology Analytics provides valuable insights from large data sets, while Pathology Informatics manages and integrates data across the entire pathology workflow. Digital Pathology Solutions streamline processes, from Pathology Workflow and Collaboration to Reporting and Integration. Pathology Services include Digital Archiving, Image Storage, Retrieval, and Decision Support. Pathology Workstations and AI Integration facilitate efficient diagnosis and patient care. Pathology Technology continues to advance, with trends towards increased automation, data sharing, and security. Pathology Scanners and Imaging Systems provide high-quality images for analysis, while Training and Education ensure professionals remain up-to-date with the latest techniques and tools.

Table of Contents:

1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation

ProductDigital Slide ScannerSoftwareApplicationHospitals And LaboratoriesIndependent And Small ClinicsResearch CentersGeographyNorth AmericaEuropeAsiaRest Of World (ROW)

7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Trends
10 Company Landscape
11 Company Analysis
12 Appendix

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

View original content to download multimedia:https://www.prnewswire.com/news-releases/digital-pathology-market-size-is-set-to-grow-by-usd-1-12-billion-from-2024-2028–growing-adoption-of-iot-infrastructure-among-laboratories-boost-the-market-technavio-302209857.html

SOURCE Technavio

Related Topics:
Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Ontario Superior Court Awards Over $170 Million in Damages to Mutual Fund Investors in Landmark Class Action Decision

Published

60 minutes ago

on

July 18, 2026

By

TORONTO, July 17, 2026 /PRNewswire/ — On July 16, 2026, Justice Markus Koehnen of the Ontario Superior Court of Justice ordered CI Mutual Funds Inc. and AIC Limited to pay Class Members damages and interest in excess of $170 million.

The Market Timing class action, commenced in 2006, alleged that certain mutual fund managers permitted sophisticated offshore hedge fund investors to engage in frequent trading in their funds, that substantially diluted the investment of long-term investors, including retail unitholders, many of whom were retirees.

Rochon Genova has represented the long-term investors since the inception of this case, including before the Supreme Court of Canada, on appeal from an earlier certification motion.  The Supreme Court certified the case in 2013. A subsequent case management order divided the trial into two phases: a trial in respect of liability, and a subsequent trial in respect of damages. The liability trial was held in February, March and June 2022.

On February 13, 2023, Justice Koehnen issued reasons for judgment in respect of the liability trial.  Justice Koehnen found that both CI and AIC breached their duty of care to prevent “market timing” in their funds. The liability decision, indexed as Fischer v. IG Investment, 2023 ONSC 915, is available here.

The damages trial was heard before Justice Koehnen between March 28 and May 16, 2025. Closing submissions were heard on July 30, August 6 and August 7, 2025. In total, Class Counsel spent 41 days in trial on liability (24 days) and damages (17 days). On June 16, 2026, Justice Markus Koehnen of the Superior Court of Justice issued reasons for judgment in respect of the damages trial.

The Court accepted the evidence of the Plaintiffs’ expert, Professor Eric Zitzewitz, and determined that the “Next Day NAV method” of calculating damages was the appropriate methodology to use, as it measures the specific harm that the time zone arbitrage at issue caused, harm referred to as dilution.

Justice Koehnen determined that the “profits method”, the method of calculating damages advocated for by CI’s expert, was not appropriate as it “measures the wrong thing”. The Court determined that on a balance of probabilities, the “prerequisites of using the profits method” had not been met.

Ultimately, with respect to CI, the Court awarded the Plaintiffs $60,480,000 in damages for the harm resulting from CI’s failure to take appropriate steps to prevent market timing by certain Identified Accounts.

The Court also awarded the Plaintiffs damages caused by specific Additional Accounts at CI that were identified by the Plaintiffs’ expert, Professor Zitzewitz, as having engaged in market timing that harmed the unit holders.

With respect to AIC, the Court awarded the Plaintiffs a total of $37,900,659 in damages, which includes damages caused by the Identified Accounts, and Additional Accounts at AIC that were identified by the Plaintiffs’ expert as having engaged in market timing. 

The Court determined the Plaintiffs are also entitled to pre-judgment interest in the amount of 2.8% per annum, to be applied to the damages figures set out above, in addition to costs against both Defendants.

Peter Jervis, a senior partner at Rochon Genova who led the prosecution of this case, stated: “The damages decision sends a clear message that those who fail to safeguard investors from harmful market practices will be held accountable. That this result was achieved after two decades of hard-fought litigation, is a testament to the perseverance of the Representative Plaintiffs and Class Counsel, and to the strength of our judicial system in delivering access to justice in complex cases.”

Joel Rochon, the Managing Partner of Rochon Genova added: “The decision is an important victory not only for the Class Members, but for the integrity of Canadian capital markets. Mutual funds are a cornerstone of the retirement savings of millions of everyday Canadians, and investors are entitled to expect that fund managers will protect them from practices that unfairly dilute the value of their investments.”

The Plaintiffs in this action were represented by Peter Jervis, Joel Rochon, Sarah Fiddes and Jessica Marshall.

For further updates, please visit Rochon Genova’s website here.

View original content:https://www.prnewswire.com/news-releases/ontario-superior-court-awards-over-170-million-in-damages-to-mutual-fund-investors-in-landmark-class-action-decision-302828857.html

SOURCE Rochon Genova

Continue Reading

Technology

Global Commercial Service Robot Shipments Leader KEENON Puts Humanoids to Work at WAIC 2026

Published

60 minutes ago

on

July 18, 2026

By

SHANGHAI, July 18, 2026 /PRNewswire/ — At WAIC 2026, KEENON Robotics is bringing humanoid and specialized service robots onto the same stage—not as competing concepts, but as complementary forms of embodied intelligence working across complete commercial service workflows.

According to IDC, KEENON ranked first worldwide in commercial service robot shipments in 2025, while maintaining its leadership in the global delivery robot market. IDC also sees the industry moving toward a more diversified, multi-form future, where different robot types are deployed according to the needs of specific tasks and environments. KEENON first propose such strategy and WAIC showcase brings that trend to life.

At the booth, the newly introduced hotel laundry scenario demonstrates this approach most clearly. Humanoid robots complete operational tasks such as loading and operating washing machines, retrieving clean laundry, and folding garments, while the DINERBOT T9 supports the wider delivery workflow. Together, they show how humanoid and specialized robots can divide responsibilities and collaborate within a real hotel operation.

Beyond the hotel workflow, KEENON applies the same role-based approach to food and retail service. Drawing on years of customer insight from restaurants and stores, XMAN-R1 takes on front-of-house tasks that combine interaction with object handling—from preparing drinks with NOWWA Coffee to responding to customer requests in dessert and retail settings. Rather than presenting isolated demonstrations, these scenarios show how KEENON is extending proven commercial service workflows into new humanoid capabilities, with every task performed autonomously and without teleoperation.

Through its “general-purpose humanoid + specialized service robot” strategy, KEENON is building a practical path for embodied intelligence: humanoids take on flexible operation and interaction tasks, while specialized robots continue to handle high-frequency delivery and cleaning. At WAIC 2026, KEENON is showing not just more robot forms, but a more complete model for commercial deployment.

With more than 100,000 service robots deployed worldwide across over 70 countries and regions, KEENON has been recognized by global renown brands across various sectors and widely deployed at major brands like Burger King, Buffalo Wild Wings, Hilton, BMW, Lego etc. From 10 to 20+ robots operating in single venues like Hotel Around Pyeongchang to a mixed fleet of 8 robots across 6 types at facilities like Shangri-La’s Trader Hotel, making it world-first intelligent hotel with both humanoid and service robot, KEENON delivers proven multi-robot efficiency.

SOURCE KEENON Robotics Co., Ltd.

Continue Reading

Technology

MDT Introduces TMR1370 Ultra-Low-Power Magnetic Switch IC Enabling More Than Two Years of Standby Operation in CGM Devices

Published

2 hours ago

on

July 18, 2026

By

— Next-Generation TMR Magnetic Switch with Ultra-Low 50nA Maximum Supply Current Expands MDT’s Proven CGM Sensor Portfolio

ZHANGJIAGANG, China, July 18, 2026 /PRNewswire/ — MultiDimension Technology Co., Ltd. (MDT), a leading supplier of magnetic sensors and a pioneer in Tunneling Magnetoresistance (TMR) technology, today introduced the TMR1370 ultra-low-power magnetic switch IC, the newest addition to MDT’s magnetic sensing portfolio for continuous glucose monitoring (CGM) devices. Building on the proven TMR1367, TMR1368, and TMR1369 family, the TMR1370 delivers significantly lower power consumption, enhanced voltage compatibility, and a smaller package to enable next-generation CGM systems with ultra-long standby life.

Optimized for battery-powered CGM devices, the TMR1370 features a maximum supply current of only 50nA, with approximately 30nA typical at a 3V supply. When combined with the magnetic wake-up mechanism widely adopted in CGM devices, the TMR1370 enables more than two years of standby operation, helping extend product shelf life while preserving battery capacity for continuous glucose monitoring after activation.

The TMR1370’s exceptional power efficiency is enabled by MDT’s proprietary TMR technology platform, which combines advanced magnetic sensor design, optimized device architecture, and proprietary wafer process technology to achieve high magnetic sensitivity together with ultra-low power consumption. Complementing MDT’s existing X-axis and Z-axis CGM magnetic switch portfolio, the TMR1370 gives system designers greater flexibility to optimize sensor orientation and mechanical layout for a wide variety of CGM architectures while enabling easy migration from previous-generation devices.

Key Features

Enables more than two years of standby operation in battery-powered CGM devices.50nA maximum supply current, approximately 30nA typical at 3V.Wide 1.8V to 4.0V operating-voltage range.Maximum operating point below 40 Gauss for reliable magnetic wake-up detection.X-axis magnetic sensing optimized for compact CGM designs.Miniature DFN5L package (1.6×1.6×0.5mm) for thinner and lighter wearable medical devices.Complements MDT’s proven X-axis and Z-axis CGM magnetic switch portfolio for flexible system design and simplified migration.

Samples of the TMR1370 are available through DigiKey and MDT’s online store at www.tmr-sensors.com. For volume pricing, delivery information, and technical specifications, contact MDT Global Sales at sales@dowayusa.com.

About MDT
MultiDimension Technology was founded in 2010 in Zhangjiagang, Jiangsu Province, China, with branch offices in Shenzhen, Chengdu, and Ningbo in China, Singapore, Tokyo, Japan, and San Jose, Calif., USA. MDT has developed a unique intellectual property portfolio, and its self-owned state-of-the-art TMR manufacturing facilities that can support volume production of high-performance, low-cost TMR magnetic sensors to satisfy the most demanding application needs. Led by its core management team of elite experts and veterans in magnetic sensor technology and engineering services, MDT is committed to creating added value for its customers and ensuring their success. For more information about MDT please visit http://www.multidimensiontech.com.

Media Contacts
MDT sales department, sales@dowayusa.com, sales@dowaytech.com
Tel: +1-650-275-2318 (US), +86-189-3612-1156 (China)

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/mdt-introduces-tmr1370-ultra-low-power-magnetic-switch-ic-enabling-more-than-two-years-of-standby-operation-in-cgm-devices-302828591.html

SOURCE MultiDimension Technology Co., Ltd.

Continue Reading

Trending